Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

SHBG may be a useful early indicator and treatment target for PCOS.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Alopecia in captive rhesus macaques is affected by season, sex, age, housing, and stress, with complex links between stress hormones and hair loss.

Skin problems are common and important signs of eating disorders and treating the eating disorder can improve these skin conditions.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Some men with early hair loss may have a condition similar to PCOS in women.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

PRP treatment can safely boost hormone levels in some IVF patients with low ovarian reserve.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.